Document is current
Any future updates will be listed below
-
Authors
Michiels, Emiel http://orcid.org/0000-0001-6065-5576
Roose, Kenny http://orcid.org/0000-0002-5270-4603
Gallardo, Rodrigo http://orcid.org/0000-0003-1584-3564
Khodaparast, Ladan
Khodaparast, Laleh
van der Kant, Rob http://orcid.org/0000-0003-3639-9749
Siemons, Maxime
Houben, Bert http://orcid.org/0000-0002-6750-011X
Ramakers, Meine
Wilkinson, Hannah
Guerreiro, Patricia
Louros, Nikolaos
Kaptein, Suzanne J. F. http://orcid.org/0000-0002-7935-0219
Ibañez, Lorena Itatí http://orcid.org/0000-0002-9393-2004
Smet, Anouk
Baatsen, Pieter
Liu, Shu
Vorberg, Ina http://orcid.org/0000-0003-0583-4015
Bormans, Guy
Neyts, Johan
Saelens, Xavier http://orcid.org/0000-0002-3861-6965
Rousseau, Frederic http://orcid.org/0000-0002-9189-7399
Schymkowitz, Joost http://orcid.org/0000-0003-2020-0168
- License Information
-
More Information
Article History
Received: 21 June 2019
Accepted: 12 May 2020
First Online: 5 June 2020
Competing interests
: The authors declare the following competing interests: J.S. and F.R. are listed as inventors of patents held by their hold institution VIB, covering the peptides described in this manuscript, and which are licensed to Aelin Therapeutics (Leuven, Belgium), of which J.S. and F.R. are the scientific founders. All other authors declare no competing interests.
